Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunoglobulin
Pharma
FDA grants Calliditas full nod for kidney disease drug Tarpeyo
Two years after securing an accelerated approval for its IgAN therapy Tarpeyo, Calliditas has scored a full FDA endorsement for the drug.
Kevin Dunleavy
Dec 20, 2023 5:24pm
Novartis shows strong Fabhalta results in another blood disorder
Dec 11, 2023 11:20am
Novartis gains first FDA approval for touted blood disorder drug
Dec 6, 2023 11:02am
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
FDA blesses Takeda's HyQvia to treat children with PI
Apr 12, 2023 10:10am
Europe blesses Calliditas' kidney disease drug Kinpeygo
Jul 18, 2022 11:09am
